NIK inhibitors (SignalChem)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameNIK inhibitors (SignalChem)
Drug Alias NameNFkappaB inducing kinase inhibitors (MetaSignal)NFkappaB inducing kinase inhibitors (SignalChem)NIK inhibitors (MetaSignal)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-Activated Protein Kinase Kinase Kinase 14 inhibitors
TargetsMitogen-Activated Protein Kinase Kinase Kinase 14
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSignalchem Lifesciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSignalchem Lifesciences
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A